Address

The Enriqueta Villavecchia Foundation for Infantile Oncology
The Enriqueta Villavecchia Foundation for Infantile Oncology
The Enriqueta Villavecchia Foundation for Infantile Oncology
infantile cancer

Child Cancer

Cancer in Children

Cancer develops when a change in the DNA transforms a normal cell into a malignant one.

The mechanisms that facilitate this genetic alteration are complex and not well understood. Sometimes, in specific cases, the existence of physical, chemical or biological environmental factors may cause a lesion.

In recent decades the advances in diagnosis and treatment of related illnesses have greatly increased a child’s possibility of survival. Cancer, however, continues to be the second cause of death in children under 15 – only outnumbered by accidents.

In the 1950’s the cure rate for cancer was no more than 20%. Today, 75% of cases reported globally are considered curable, especially when the illness is diagnosed at an early stage.

The occurence of different types of cancer related illnesses varies with age. The most frequent are leukaemia, brain tumours, lymphomas, bone tumours and thyroid carcinomas.


The general processes for dealing with tumours is as follows:

  • Phase 1: Diagnosis
    Radiology, CAT Scan, MRI, Sonogram, Radioisotopes, Histology, Microscopy, Genetic, etc.

  • Phase 2: Treatment
    Surgery, Radiotherapy, Chemotherapy, Bone Marrow Transplant.

  • Phase 3: Evolutionary Control
    If after treatment of infections with the most appropriate antibiotics we can say that it is now cured and should not recur. Unfortunately the same cannot be said of cancer. After appropriate treatment and positive results, the patient goes into the follow-up phase of evolutionary control. A worst case scenario would be a missed malignant cell at the larvae stage, or in remission, could suddenly become virulent.

The first year after the end of the treatment is the time when a patient is most likely to suffer a relapse. For this reason the child must submit to clinical, analitical and radiological tests. After the first year the possibilty of a relapse diminishes but continues to exist. For this reason testing is carried out during the next five years - albeit less frequently.



© The Enriqueta Villavecchia Foundation for Infantile Oncology | Legal Notice

Creado por Signia